• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926220250
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Rash (2033); Skin Irritation (2076); Toxemia (2207)
Event Date 10/23/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id# 2134265-2017-12192.It was reported that skin issues occurred.In (b)(6) 2017, a patient underwent a repeat coronary angiography for stenosis.2.5 x 8 and 2.5 x 20 synergy drug eluting stents were implanted.Iodixanol radiocontrast was used during the procedure.In (b)(6) 2017, the patient presented with an erythematous non-pruriginous rash evocative of toxidermia, affecting the trunk, the limbs, respecting the face, with no mucosal injury.A biopsy was consistent with the proposed diagnosis of toxidermia.Testing was performed and then an iodinated contrast product was introducted.There was initial improvement of the rash and hypereosinophilia and after that the rash and hypereosinophilia reoccurred.The rash has evolved towards the persistence of some eczematiform lesions in the lower back.The hypereosinophilia has regressed.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the physician did not know if the skin reaction occurred because of the synergy stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7108326
MDR Text Key94512929
Report Number2134265-2017-12193
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberH7493926220250
Device Catalogue Number39262-2025
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/03/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CONTRAST AGENT: VISIPAQUE
Patient Outcome(s) Required Intervention;
-
-